Matt Hewitt
Stock Analyst at Craig-Hallum
(4.21)
# 505
Out of 4,734 analysts
45
Total ratings
55.26%
Success rate
15.28%
Average return
Main Sectors:
Stocks Rated by Matt Hewitt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLOV Clover Health Investments | Initiates: Buy | $6 | $4.08 | +47.06% | 1 | Dec 17, 2024 | |
| CSBR Champions Oncology | Maintains: Buy | $6 → $8 | $9.78 | -18.20% | 3 | Dec 12, 2024 | |
| BLFS BioLife Solutions | Maintains: Buy | $30 → $32 | $26.14 | +22.42% | 4 | Nov 13, 2024 | |
| OMCL Omnicell | Maintains: Buy | $45 → $64 | $42.57 | +50.34% | 6 | Oct 31, 2024 | |
| LGND Ligand Pharmaceuticals | Maintains: Buy | $135 → $140 | $111.89 | +25.12% | 3 | Jul 9, 2024 | |
| SLP Simulations Plus | Reiterates: Buy | $56 | $29.92 | +87.17% | 7 | Jul 3, 2024 | |
| NOTV Inotiv | Maintains: Buy | $25 → $10 | $4.27 | +134.19% | 3 | May 16, 2024 | |
| SDGR Schrödinger | Maintains: Buy | $35 → $30 | $19.00 | +57.89% | 3 | May 2, 2024 | |
| CDMO Avid Bioservices | Maintains: Buy | $22 → $16 | $12.39 | +29.14% | 4 | Dec 8, 2023 | |
| MXCT MaxCyte | Initiates: Buy | $7 | $4.94 | +41.70% | 1 | Nov 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $207 → $200 | $160.51 | +24.60% | 3 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $3.21 | +211.53% | 1 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $67 → $30 | $9.09 | +230.03% | 5 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $400 | $2.37 | +16,777.64% | 1 | Jan 4, 2022 |
Clover Health Investments
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $4.08
Upside: +47.06%
Champions Oncology
Dec 12, 2024
Maintains: Buy
Price Target: $6 → $8
Current: $9.78
Upside: -18.20%
BioLife Solutions
Nov 13, 2024
Maintains: Buy
Price Target: $30 → $32
Current: $26.14
Upside: +22.42%
Omnicell
Oct 31, 2024
Maintains: Buy
Price Target: $45 → $64
Current: $42.57
Upside: +50.34%
Ligand Pharmaceuticals
Jul 9, 2024
Maintains: Buy
Price Target: $135 → $140
Current: $111.89
Upside: +25.12%
Simulations Plus
Jul 3, 2024
Reiterates: Buy
Price Target: $56
Current: $29.92
Upside: +87.17%
Inotiv
May 16, 2024
Maintains: Buy
Price Target: $25 → $10
Current: $4.27
Upside: +134.19%
Schrödinger
May 2, 2024
Maintains: Buy
Price Target: $35 → $30
Current: $19.00
Upside: +57.89%
Avid Bioservices
Dec 8, 2023
Maintains: Buy
Price Target: $22 → $16
Current: $12.39
Upside: +29.14%
MaxCyte
Nov 29, 2023
Initiates: Buy
Price Target: $7
Current: $4.94
Upside: +41.70%
Aug 3, 2023
Maintains: Buy
Price Target: $207 → $200
Current: $160.51
Upside: +24.60%
Apr 13, 2023
Initiates: Buy
Price Target: $10
Current: $3.21
Upside: +211.53%
Apr 28, 2022
Maintains: Hold
Price Target: $67 → $30
Current: $9.09
Upside: +230.03%
Jan 4, 2022
Initiates: Buy
Price Target: $400
Current: $2.37
Upside: +16,777.64%